/Methods For Reducing Eosinophilic Infiltration By Administering An Anti-interleukin-4 Receptor (il4r) Antibody
Abstract
The present invention provides methods for treating, preventing or reducing the severity of eosinophilic esophagitis. The methods of the present invention comprise administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4Rα) inhibitor such as an anti-IL-4Rα antibody.
Full Text
What is claimed is:
The present invention provides methods for treating, preventing or reducing the severity of eosinophilic esophagitis. The methods of the present invention comprise administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4Rα) inhibitor such as an anti-IL-4Rα antibody.
Timeline
Filed
05/22/2026Published
09/17/2026Granted
Not AvailableIPC Codes(6)
C07K 16/28:against receptors, cell surface antigens or cell surface determinants
A61K 9/00:Medicinal preparations characterised by special physical form
A61K 31/56:Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids